Table I.
Baseline characteristics of Singaporean pulmonary arterial hypertension (PAH) patients on phosphodiesterase type 5 inhibitors (n = 114).

Baseline characteristics of Singaporean pulmonary arterial hypertension (PAH) patients on phosphodiesterase type 5 inhibitors (n = 114).
